A detailed history of Ccla Investment Management LTD transactions in Pfizer Inc stock. As of the latest transaction made, Ccla Investment Management LTD holds 44,615 shares of PFE stock, worth $1.19 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
44,615
Previous 44,615 -0.0%
Holding current value
$1.19 Million
Previous $1.25 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$26.13 - $33.94 $144,446 - $187,620
5,528 Added 14.14%
44,615 $1.28 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $345,705 - $404,095
10,773 Added 38.05%
39,087 $1.3 Million
Q2 2023

Aug 01, 2023

SELL
$36.12 - $41.79 $639,071 - $739,390
-17,693 Reduced 38.46%
28,314 $1.04 Million
Q1 2023

May 03, 2023

SELL
$39.39 - $51.28 $364,948 - $475,109
-9,265 Reduced 16.76%
46,007 $1.88 Million
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $5,338 - $6,517
-122 Reduced 0.22%
55,272 $2.42 Million
Q1 2022

Apr 29, 2022

SELL
$45.75 - $56.69 $2.08 Million - $2.58 Million
-45,527 Reduced 45.11%
55,394 $2.87 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $1.6 Million - $2.37 Million
38,757 Added 62.35%
100,921 $5.96 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $647,127 - $729,829
-19,323 Reduced 23.71%
62,164 $2.25 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $33.3 Million - $42.3 Million
-993,857 Reduced 92.42%
81,487 $3 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $6.75 Million - $7.92 Million
-212,573 Reduced 16.51%
1,075,344 $39.4 Million
Q2 2020

Oct 20, 2020

BUY
$30.12 - $36.54 $38.8 Million - $47.1 Million
1,287,917 New
1,287,917 $42.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ccla Investment Management LTD Portfolio

Follow Ccla Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccla Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ccla Investment Management LTD with notifications on news.